Phosphorylation of beta-actin by protein kinase C-delta in camptothecin analog-induced leukemic cell apoptosis
Shuang Wang1, Ying Zheng, Yun Yu
1Department of Pathophysiology, Xiangya Medical College, Central South University, Changsha, China.
Aim:
This study was conducted to reveal new proteins involved in acute myeloid leukemia (AML) cell apoptosis.
Methods:
Using camptothecin analog NSC606985- induced leukemic U937 cell apoptosis as a model, this study performed a differential proteomic analysis during apoptosis induction. The significantly modulated protein was underwent further investigation in the apoptotic process.
Results:
We found that beta-actin protein presented two different spots on the two-dimensional electrophoresis (2-DE) map, which shared similar molecular weight and different pI. Those two spots demonstrated contrary changes (disappeared on the basic-end and increased on the acid-end spot) during apoptosis induction, although the total level of beta-actin kept constant. This observation was further confirmed by immunoblot analysis on 2-DE gel. When NSC606985-treated cell lysate was incubated with alkaline phosphotase, beta-actin on the basic-end spot was restored, indicating increased phosphorylation of beta-actin during NSC606985- induced apoptosis. Moreover, the polymerization of actin also decreased after NSC606985 treatment. The increased beta-actin phosphorylation and decreased actin polymerization was antagonized by pre-treatment of rottlerin, a specific protein kinase C-delta (PKC delta) inhibitor.
Conclusion:
All these results indicate that beta-actin was phosphorylated during apoptosis induction, which was mediated by activated PKC delta.
Insights
This study reveals that beta-actin phosphorylation increases during acute myeloid leukemia (AML) cell apoptosis, mediated by protein kinase C-delta (PKC delta) activation and leading to reduced actin polymerization.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
- Understanding the molecular mechanisms of AML cell apoptosis is crucial for developing targeted therapies.
Purpose of the Study:
- To identify novel proteins involved in acute myeloid leukemia (AML) cell apoptosis.
- To investigate the role of beta-actin modulation during apoptosis induction.
Main Methods:
- Differential proteomic analysis of U937 cells induced to undergo apoptosis using camptothecin analog NSC606985.
- Two-dimensional electrophoresis (2-DE) and immunoblot analysis to assess beta-actin modifications.
- Enzyme assays to confirm phosphorylation and assess actin polymerization.
Main Results:
- Beta-actin exhibited altered phosphorylation patterns during apoptosis, with increased phosphorylation observed.
- A decrease in actin polymerization was noted following NSC606985 treatment.
- Inhibition of protein kinase C-delta (PKC delta) by rottlerin reversed the observed changes in beta-actin phosphorylation and actin polymerization.
Conclusions:
- Beta-actin phosphorylation, mediated by activated PKC delta, plays a significant role in AML cell apoptosis.
- The findings suggest a novel pathway involving beta-actin dynamics in the apoptotic process of AML cells.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways


